Stories > Alzheimer's Innovations: A Clinical Advance

Alzheimer's Innovations: A Clinical Advance

ADvantage Therapeutics Appoints Professo...

ALS Treatment Withdrawal: FDA Concerns

AMX0035 for PSP: Phase 3 Trial Commences